AMR Bio Limited
PrivateLast Round
VC Round
Sep 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AMR Bio Limited is a clinical-stage biotechnology company focused on the development and commercialization of novel anti-infectives for infection prevention.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMR Bio Limited Comparables
Compare AMR Bio Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharma Holdings | 79% | |
| GSK plc | 74% | |
| PolyPid | 71% | |
AMR Bio Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 1, 2025 |
AMR Bio Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EMV Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
$1.75M round led by EMV Capital.
AMR Bio Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AMR Bio Limited's valuation, stock price, and market status.